📰 Developing News
Page 133 - Developing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Developing. Real-time updates on events, politics, business and more.
April 4, 2023
MELBOURNE, Australia and SAN FRANCISCO, April 04, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today... | April 4, 2023
April 4, 2023
Eleven new sustainability-focused start-ups joined Societe Generales flagship Global Markets Incubator dedicated to developing ground-breaking solutions for the financial industry. From a... | April 4, 2023
April 4, 2023
Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute ... | April 4, 2023
April 4, 2023
Roseland, NJ, April 04, 2023 -- The NFT Gaming Company, Inc. , a company developing a digital gaming platform and community that will offer users the ability to create unique avatars playable in... | April 4, 2023
April 4, 2023
The popular messaging platform WhatsApp is apparently developing a new feature termed the Lock Chat.
April 3, 2023
MILAN, Italy and NEW YORK, April 03, 2023 -- Genenta Science , a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide... | April 3, 2023
April 3, 2023
Alzamend Neuro, Inc. , an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease , bipolar disorder, major depressive... | April 3, 2023
April 3, 2023
FLORHAM PARK, N.J., April 03, 2023 -- PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious... | April 3, 2023
April 3, 2023
Developing innovative therapies in NASH Corporate Presentation April 2023 DISCLAIMER ... | April 3, 2023
April 3, 2023
Zymeworks Inc. , a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor... | April 3, 2023